COMPUMED SHIPS FIRST DICOM OSTEOGRAMŽ SYSTEM
Chinese Distributor Makes Initial Placement

LOS ANGELES, April 22, 2004 -- CompuMed, Inc. (CMPD.OB) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced that it has begun shipping its DICOM OsteoGram system to international distributors.

The first system was shipped to Shanghai Sanchang Import & Export Co., LTD (SSIE), CompuMed's DICOM distributor in the People's Republic of China. Distribution by SSIE augments existing sales in China of the film-based OsteoGram system by Golden Xi Tong in Tianjin.

SSIE sold its first DICOM OsteoGram system to a prominent hospital in Zhejiang Province for integration with a major manufacturer's computed radiography (CR) platform. Implementation is slated for early May and will represent CompuMed's entry into the rapidly growing Chinese market for digital x-ray equipment. The incidence of osteoporosis is high among the Chinese population, and the government has identified the disease as one of its most important long-term health concerns.

"We are delighted to announce delivery of our first DICOM OsteoGram system to the burgeoning Chinese market," said Jerry McLaughlin, CompuMed's CEO. "We're also encouraged by how the system will be implemented. The hospital's plan reflects CompuMed's DICOM strategy, which stresses workstation consolidation. The goal is to enable clinicians to utilize software applications integrated into digital imaging platforms. This helps reduce the need for additional dedicated equipment, redundant computer workstations and specially trained staff."

The DICOM OsteoGram represents the latest advancement to CompuMed's popular software-based imaging system for screening, diagnosing and monitoring osteoporosis. It uses a digital image derived from filmless x-ray equipment to enable clinicians to perform accurate and precise osteoporosis testing. DICOM (Digital Communications and Imaging in Medicine) is the information standard that allows the new generation of medical imaging equipment to interconnect. DICOM-based systems, such as filmless x-ray platforms and PACS network servers, have become a high growth segment of the medical imaging market.

About CompuMed:

Founded in 1973, CompuMed, Inc. (OTC Bulletin Board: CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGramŽ and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram also has the capability to automatically provide an over-read (i.e., follow-up review) by a cardiologist. CompuMed is in Los Angeles. Visit CompuMed at www.compumed.net or call (310) 258-5000.

About Dutchess Advisors, LLC:

Dutchess Advisors, LLC is engaged in assisting growth companies in all facets of their long-term strategy by providing capital and progressive business solutions. Through Dutchess Private Equities Fund, LP, it manages a portfolio of private investments in public equities. Although the Company's investments are passive in nature, Dutchess provides a wide range of advisory services to assist its client companies long after the initial infusion of capital. Founded in 1996, Dutchess has been involved in excess of $200 million in financings for such companies.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by law.

CONTACT: Erik Deutsch - Tellem Worldwide, +1 (310) 479-6111 x.15, edeutsch@tellem.com